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Part I: Recommendations for Immunization Procedures
The purpose o f these recommendations is to provide information on rabies vaccines to 
practicing veterinarians, public health officials, and others concerned with rabies control. This 
document will serve as the basis for animal rabies vaccination programs throughout the 
United States. Its adoption by cooperating organizations will result in standardization of proce­
dures among jurisdictions, which is necessary for an effective national rabies-control program. 
These recommendations are reviewed and revised as necessary before the beginning of each 
calendar year. A ll animal rabies vaccines licensed by the U.S. Department of Agriculture 
(USDA) and marketed in the United States are listed in Part II o f the Compendium, and Part III 
describes the principles of rabies control.
A. VACCINE ADM INISTRATION
The Committee recommends that all animal rabies vaccines be restricted to use by or 
under the supervision of a veterinarian.
B. VACCINE SELECTION
While recognizing the efficacy of vaccines providing 1-year duration of immunity, the 
Committee recommends the use of vaccines providing 3-year duration of immunity, be­
cause their use constitutes the most effective method of increasing the proportion of 
immunized dogs and cats in comprehensive rabies-control programs.
C. ROUTE OF INOCULATION
All rabies vaccines must be administered intramuscularly at one site in the thigh.
D. HIGH-RISK RABIES AREA
An area (town, city, or county) where a high incidence of rabies exists among wildlife or 
domestic species, as determined by state health officials, may be declared a High-Risk 
Rabies Area. In such areas, the public should be alerted to the risk and urged to make sure 
their dogs and cats have current rabies vaccinations. State health officials may wish to 
consider temporarily altering revaccination schedules.
E. WILDLIFE VACCINATION
Vaccination is not recommended, since no rabies vaccine is licensed for use in wild animals 
and since there is no evidence that animal rabies vaccines produce acceptable levels of im­
munity in wild animals. The Committee recommends that neither wild nor exotic animals 
be kept as pets and that wild animals not be cross-bred with domestic dogs or cats.
F. ACCIDENTAL HUM AN EXPOSURE TO VACCINE
Accidental human inoculation may occur during administration of animal rabies vaccines. 
Exposures to inactivated vaccines constitute no known rabies hazard. No cases of rabies
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have resulted from needle or other exposure to a licensed, modified live virus vaccines in 
the United States.
G. IDENTIFICATION OF VACCINATED DOGS
The Committee recommends that all government agencies and veterinarians adopt the  
standard tag system. This will aid the administration of local, state, national, and interna­
tional procedures. Dog license tags should not conflict in shape and color with rabies tags. 
It is recommended that anodized aluminum rabies tags not be less than 0 .0 6 4  inches in 
thickness.
1. Rabies Tags:





2. Rabies Certificate: Government agencies and veterinarians should use the NASPHV 
form #50 , Rabies Vaccination Certificate, which can be obtained from vaccine 
manufacturers.
Part II: Vaccines Marketed in United States and 
NASPHV Recommendations










A. MODIFIED LIVE VIRUS





















Bio-Ceutic Dogs 1 ml
3 mos. & 
1 yr. later T riennially







Bio-Ceutic Dogs 1 ml 3 mos. Annually
B. INACTIVATED
Murine origin FORT DODGE TRIMUNE 3 mos. &
License No. 112 Fort Dodge Dogs 1 ml 1 yr. later Triennially
Cats 1 ml 3 mos. & T riennially
1 yr. later
Murine origin FORT DODGE ANNUMUNE Dogs 1 ml 3 months Annually
License No. 112 Fort Dodge Cats 1 ml 3 months Annually
Murine origin DOUGLAS BIORAB-1 Dogs 1 ml 3 months Annually
License No. 165-B Schering
Veterinary Cats 1 ml 3 months Annually
Murine origin DOUGLAS BIORAB-3 Dogs 1 ml 3 mos. &
License No. 165-B Schering 1 yr. later T riennially
Veterinary Cats 1 ml 3 months Annually
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Vaccine: generic nam e Produced by
Product nam e  









Murine origin VACCINES, INC. DURA-RAB 1 Dogs 1 ml 3 months Annually
License No. 277 Wildlife vaccines
& Tech America Cats 1 ml 3 months Annually
Hamster cell line origin BEECHAM RABCINE Dogs 1 ml 3 months Annually
License No. 225 Beecham Cats 1 ml 3 months Annually
Hamster cell line origin BEECHAM RABCINE-FELINE
License No. 225 Beecham Cats 1 ml 3 months Annually
Porcine cell line origin NORDEN ENDURALL-K Dogs 1 ml 3 months Annually
License No. 189 Norden Cats 1 ml 3 months Annually
Porcine cell line origin NORDEN RABGUARD-TC Dogs 1 ml 3 mos. &
1 yr. later Triennially
License No. 189 Norden Cats 1 ml 3 mos. &
1 yr. later Triennially
Monkey cell line origin WELLCOME CYTORAB Dogs 1 ml 3 months Annually
License No. 107 Wellcome Cats 1 ml 3 months Annually
Monkey cell line origin WELLCOME TRIRAB & Dogs 1 ml 3 mos. &
DELTA-RAB 1 yr. later Triennially
License No. 107 Wellcome Fromm Cats 1 ml 3 months Annually
Feline cell line origin FROMM RABVAC Dogs 1 ml 3 months Annually
License No. 195-A Fromm Cats 1 ml 3 months Annually
Hamster cell line origin MERIEUX IMRAB Dogs 1 ml 3 mos. &
License No. 298 Pitman-Moore 1 yr. later Triennially
Sheep 1 ml 3 mos. &
1 yr. later T riennially
Cats 1 ml 3 months Annually
Cattle 2 ml 3 months Annually
C. C O M B IN A T IO N
Feline cell line origin FROMM ECLIPSE 3 KP-R Cats 1 ml 3 months Annually
License No. 195-A Fromm
Feline cell line origin FROMM ECLIPSE 4 KP-R Cats 1 ml 3 months Annually
License No. 195-A Fromm
Monkey cell line origin WELLCOME CYTORAB RCP Cats 1 ml 3 months Annually
License No. 107 Wellcome
Murine origin FORT DODGE FEL-O-VAX Cats 1 ml 3 mos. & Triennially
License No. 112 PCT-R 1 yr. later
Fort Dodge
•Refers only to domestic species of this class of animals.
^All vaccines must be administered intramuscularly at one site in the thigh.
§Three months is the earliest age recommended. Dogs and cats vaccinated between 3 and 12 months should be revac­
cinated 1 year later.
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Part III: Principles of Rabies Control
These guidelines have been prepared by the National Association o f State Public H ealth  
Veterinarians (NASPHV) for use by government officials, practicing veterinarians, and others  
who may become involved in certain aspects of rabies control. The NASPHV plans to annually 
review and revise these recommendations as necessary. Standardized control procedures a re  
needed to deal effectively with the public health aspects of rabies.
A. PRINCIPLES OF RABIES CONTROL
1. Rabies in Humans: Rabies in humans can be prevented by eliminating exposure to  
rabid animals and by promptly treating local wounds and immunizing when exposed. 
Current recommendations of the Public Health Service Immunization Practices Advisory 
Committee (ACIP) for pre-exposure and post-exposure prophylaxis are suggested fo r  
attending physicians. These recommendations, along with the current status of animal 
rabies in the region and information concerning the availability of rabies biologies, are  
available from state health departments.
2. Domestic Animals: Local governments should initiate and maintain effective programs 
to remove strays and unwanted animals and ensure vaccination of all dogs and cats.
(Continued on page 6 7 3 )
TABLE I. Summary—cases specified notifiable diseases, United States
51 st Week Ending Cumulative. 51 st Week Ending











19 7 8 -1 9 8 2
Aseptic meningitis 96 184 113 11,600 9,524 8,341
Encephalitis: Primary (arthropod-borne
& unspec.) 16 22 20 1,679 1,562 1 .1 8 0
Post-infectious . . 1 69 79 2 1 0
Gonorrhea: Civilian 12,250 18,393 18,393 875,638 941,032 9 8 3 ,1 0 4
Military 274 165 424 23,298 25,146 2 6 .2 3 0
Hepatitis: Type A 265 376 495 21,254 22,582 2 7 ,9 3 0
Type B 271 419 378 22,292 21,589 18.141
Non A, Non B 35 53 N 3,274 2,458 N
Unspecified 101 158 179 7,460 8,500 10 ,3 4 5
Legionellosis 8 11 N 696 641 N
Leprosy . 3 3 229 230 2 1 8
Malaria 4 8 9 759 1,019 1 ,0 1 9
Measles: Total* 8 39 39 1,436 1,680 1 3 ,3 7 5
Indigenous 7 N N 1,136 N N
Imported 1 N N 300 N N
Meningococcal infections: Total 30 51 60 2,645 2,951 2 .6 6 0
Civilian 30 51 60 2,629 2,937 2 .641
Military . . . 16 14 19
Mumps 46 62 151 3,227 5,208 8 ,3 6 5
Pertussis 28 61 34 2,207 1,764 1 .6 3 6
Rubella (German measles) 7 26 38 942 2,281 3 .7 8 7
Syphilis (Primary & Secondary): Civilian 474 489 464 31,419 32,287 2 6 ,9 6 0
Military 7 . 3 377 424 3 1 7
Toxic-shock syndrome 4 N N 382 N N
Tuberculosis 326 503 582 23,061 25,115 2 6 .7 9 3
Tularemia 8 5 2 311 255 2 3 0
Typhoid fever 3 8 8 436 393 5 1 3
Typhus fever, tick-borne (RMSF) 4 4 4 1,132 960 1 .0 4 2
Rabies, animal 57 68 68 5,693 6,058 6 .0 5 8




Cum. 1 9 8 3  
3 9
Botulism: Foodbome (Pa. 1) 20 Poliomyelitis: Total 8
Infant (Pa. 1, Hawaii 1) 70 Paralytic 8
Other 3 Psittacosis 1 1 8
Brucellosis (Conn. 1, Ala. 1, Tex. 1) 182 Rabies, human 2
Cholera 1 Tetanus (Va. 1) 7 4
Congenital rubella syndrome 20 Trichinosis 3 2




Typhus fever, flea-borne (endemic, murine) 4 8
•One of the 8 reported cases for this week was imported from a foreign country or can be directly traceable to a known internationally im ­
ported case within two generations.
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TABLE III .  Cases of specified notifiable diseases. United States, weeks ending







Hepatitis (Viral), by type
Legionel-














UNITED STATES 96 1,679 69 875,638 941.032 265 271 35 101 8 229 759
NEW ENGLAND 4 61 . 23,842 22,681 9 25 2 11 2 3 38
Maine - - - 1,102 1,193 . 1 _ 1
N.H. - 5 - 709 742 . . _ . _ 1 2
Vt. - 1 - 434 416 1 1 . . . 1
Mass. 2 28 - 10,136 10,143 6 12 2 10 . . 18
R.l. - 1 - 1,256 1,542 . . . . 1 4
Conn. 2 26 - 10,205 8,645 2 11 - 1 2 1 12
MID ATLANTIC 31 134 7 114,527 119,499 34 75 6 11 27 110
Upstate N Y. 5 33 - 18,364 19,696 6 19 1 2 _ 32
N Y. City 6 13 - 46,132 48,939 10 13 . _ 26 28
N.J. 12 19 1 21,360 21,815 4 19 3 9 . . 28
Pa. 8 69 6 28,671 29,049 14 24 2 - - 1 22
E.N. CENTRAL 13 587 20 121,886 135,958 105 37 9 11 5 6 54
Ohio 6 196 9 32,262 35.376 91 20 4 2 5 1 9
Ind. 1 185 1 12,694 16,514 4 8 5 4 . . 7
III. - 17 7 32,117 39,584 2 5 . 1 . 2 18
Mich. 6 125 - 33,380 32,597 8 4 . 4 . 3 15
Wis * 64 3 11,433 11,887 - - - - - - 5
W N CENTRAL 2 169 10 40,582 43,994 4 18 1 1 . 6 32
Minn 1 70 1 5,781 6,367 1 5 . . . 4 11
Iowa - 58 - 4,498 4,780 1 3 . 1 . . 4
Mo. - 30 - 19,499 20,838 1 8 1 . . 1 5
N Dak. - 4 - 435 562 - - . - . . 2
S Dak - 1 2 1,036 1,102 . . . . . 1
Nebr. - 4 - 2,695 2,605 . . . . . . 3
Kans. 1 2 7 6,638 7,740 1 2 - - - 1 6
S ATLANTIC 24 235 16 228,831 243.726 15 47 10 17 1 13 120
Del - 1 - 4,130 4,077 1 . . . . . 1
Md 1 23 - 29,466 30,829 1 11 1 3 1 1 21
DC U - - 15,344 14,987 U U u U U . 16
Va 5 60 2 20,853 19,674 2 8 3 4 . 1 30
W Va - 47 - 2,571 2,739 1 1 . 1 . . 3
NC 3 47 - 35,403 38,767 2 3 . 1 . 2 4
SC U 5 - 20,619 23,820 U U U U u . 5
Ga. 3 9 2 48,615 47,624 2 3 1 1 . 1 10
Fla 12 43 12 51,830 61,209 6 21 5 7 - 8 30
E S. CENTRAL 3 67 2 73,329 81,646 13 21 1 . . . 14
Ky. 3 16 - 8,744 10,803 5 4 . . . . 2
Tenn. - 19 - 29,948 32,100 3 12 1 . . .
Ala - 24 - 22,528 24.401 4 4 . . . . 7
Miss. - 8 2 12,109 14,342 1 1 - - - - 5
W S CENTRAL 13 168 2 123.270 129,570 49 32 1 47 35 67
Ark. - 13 - 9,752 10,323 1 2 . 2 . 1
La. - 20 - 23,664 23,326 . . . . . 1 8
Okla. 2 30 1 14,146 14,353 5 5 1 5 . 10
Tex. 11 105 1 75,708 81,568 43 25 - 40 - 34 48
MOUNTAIN 1 79 4 27,892 31,456 15 13 3 1 14 29
Mont. - 2 - 1,204 1,307 1 1 . . .
Idaho - 1 - 1,255 1,493 2 . 1 1 . . 2
Wyo U 2 - 725 942 U U U U u . 1
Colo. 1 48 - 7,789 8,445 8 5 1 . _ 2 10
N.Mex. - 2 - 3.447 4,328 . 2 . . . . 5
Ariz. u 11 4 7,857 8,168 U U u u u 10 8
Utah - 12 - 1,348 1,560 1 . 1 2 3
Nev. - 1 - 4,267 5,213 3 5 - - -
PACIFIC 5 179 8 121,479 132,502 21 3 2 2 125 295Wash. - 13 1 9,495 11,164 4 . . 1 _ 16 16Oreg. - - 4 6,546 7,702 16 1 1 1 _ 1 12Calif U 157 3 99,994 107,683 U U U U u 73 265Alaska - - - 3,158 3,397 1 1 .
Hawaii 5 9 - 2,286 2,556 - 1 1 - - 35 2
Guam U . . 114 136 U u U u u 2 2PR. - 1 1 * 2,615 2,548 1 . 3 3V.l. - - - 297 279 _ 2 .
Pac. Trust Terr. U " - - 388 U U U u u - -
U: Unavailable
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TABLE I I I .  (Cont.'d). Cases of specified notifiable diseases. United States, weeks ending
December 24 ,1983 and December 25 ,1982  (51st week)
Reporting Area Indigenous Imported* Total
1983 I Cum. 





UNITED STATES 7 1,136 1 300 1,680
NEW ENGLAND - 5 16 14
Maine . _
N.H. . . 3 3Vt. _ . . 2
Mass. - 4 . 5 3R.l. _ _ _
Conn. - 1 - 8 6
MID ATLANTIC . 75 . 44 169
Upstate N Y. - 5 . 13 112
N Y. City - 44 _ 27 44
N.J. . 26 . 1 6
Pa. - - 3 7
E.N. CENTRAL _ 649 1 59 84
Ohio - 72 1 + 16 1
Ind. - 402 - 4 2
III. - 173 . 33 24
Mich. - 2 _ 5 57
Wis. - - - 1
W.N. CENTRAL . 1 7 49
Minn. _ 1 _
Iowa _ _ _ _
Mo. - . _ 1 2
N. Dak. . . _ _
S. Dak. . _ _ .
Nebr. . _ _ _ 3
Kans. - - - 6 44
S. ATLANTIC . 173 . 31 243
Del. . . _
Md. - 6 . 4 5
DC. U . U . 1
Va. - 10 . 13 14
W. Va. . . 3
N.C. . . . 1 2
S.C. u . u 4
Ga. - 8 _
Fla. - 149 9 218
E.S. CENTRAL _ 3 . 24 12
Ky. - . 1 1
Tenn. . . _ 6
Ala. . 1 _ 4 2
Miss. - 2 - 19 3
W.S. CENTRAL _ 44 _ 35 170
Ark. - 5 - 8
La. - 4 . 25 14
Okla. - 1 . 30
Tex. - 34 - 2 126
MOUNTAIN 7 22 18 29
Mont. . . _ 4
Idaho _ _ _ 10
Wyo. U . u 1
Colo. . _ 3 8
N.Mex. . _ _
Ariz. u . u 1 17
Utah 7 22 _ . 3
Nev. - - -
PACIFIC _ 164 66 910
Wash. - 2 . 33 42
Oreg. - 8 2 17
Calif. U 153 u 29 845Alaska _ _ 2 1
Hawaii - 1 - 5
Guam u 1 u 1 9
PR. - 94 . 221VI. . . _ 5















2,645 46 3,227 5,208 28 2,207 1 ,784 7
148 1 130 188 . 73 64
10 - 22 43 . 5 4 _
6 - 27 18 . 10 12 _11 - 15 7 . 8 2 _47 1 29 75 . 38 30 _11 - 16 18 . 5 11 .
63 - 21 27 - 7 5 -
444 5 372 339 8 392 534 2
143 4 109 96 . 121 315 2
75 - 41 47 . 53 47
79 - 139 55 . 20 24 _
147 1 83 141 8 198 148 -
493 28 1,424 2,644 4 482 354 1
148 5 5 9 t 1,756 4 155 95
54 - 56 49 . 60 25 .
141 11 167 307 _ 156 164 .
88 12 519 401 . 42 30 1
62 - 91 131 - 69 40
140 3 172 639 1 143 82 1
28 - 30 455 1 49 34
20 - 44 63 . 9 9
55 - 19 13 - 18 17
4 - 1 _ _ 3
4 - - 1 . 8 6
5 - 4 1 . 2 1
24 3 74 106 - 54 15 1
539 4 231 327 1 246 283
11 1 9 13 . 5 8 .
54 1 44 34 . 20 73 _
8 U - U . _ U
79 1 37 44 . 50 29
3 1 62 120 9 14 .
105 - 14 23 . 31 45 .
51 u 14 18 u 14 16 u
90 - 51 29 - 65 42
138 N - 46 1 52 56 -
153 . 59 67 . 34 52
30 - 21 22 - 14 6 .
52 - 32 25 _ 9 26 .
49 - 2 10 - 5 5 .
22 - 4 10 - 6 15 -
271 4 223 262 11 461 107 3
22 - 3 8 1 26 6
47 - 1 6 . 12 22 _
36 N - - 5 335 8 .
166 4 219 248 5 88 71 3
122 . 182 123 3 226 82
30 - 7 8 _ 2 1 .
9 - 8 5 . 15 12 .
2 U 4 2 U 6 4 U
38 - 53 22 3 137 32
7 N - - . 14 8 .
23 U 93 56 U 29 21 u
12 - 12 22 . 22 4 .
1 • 5 8 - 1 - -
335 1 434 619 _ 150 206
49 1 54 102 . 20 36 .
60 N - - . 9 27 .
215 U 344 481 u 114 115 u
4 - 16 15 - 4 .
7 - 20 21 - 3 28 -
1 U 1 5 u . . u
11 - 145 104 _ 14 22
- - - 4 . . . _







































































































•For measles only, imported cases includes both out-of-state and international importations. 
—M Nnt nntifiahlp------LJ Un»i/«ih»hl« T International yOut-nf-st»tw
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TABLE II I .  (Cont. d). Cases of specified notifiable diseases, United States, weeks ending
































UNITED STATES 31,419 32,287 4 326 23,061 311 436 1,132 5,693
NEW ENGLAND 681 605 12 705 4 19 6 37
Maine 19 8 1 37 _ 9
N.H. 27 5 . 34 _ . 1 5
Vt. 3 7 . 12 . . 2
Mass. 435 407 11 386 3 14 2 14
R.l. 22 27 . 62 1 1 1
Conn. 175 151 - 174 - 4 3 6
MID ATLANTIC 4,132 4,367 . 80 4.181 1 75 28 266
Upstate N.Y. 316 461 - 8 698 1 11 7 75
NY. City 2,434 2,558 - 27 1,667 . 27 2 .
N.J. 811 640 - 11 842 _ 31 8 24
Pa. 571 708 - 34 974 - 6 11 167
E.N. CENTRAL 1,622 1,914 2 84 3,142 4 63 69 471
Ohio 446 333 2 24 512 . 18 27 60
Ind. 151 199 - 16 375 _ 4 16 30
III. 695 1,002 . 19 1,321 1 29 17 240
Mich. 236 279 . 18 776 1 10 7 20
Wis 94 101 - 7 158 2 2 2 121
W.N. CENTRAL 384 550 2 10 715 96 13 56 817
Minn. 147 143 1 - 153 - 2 - 143
Iowa 22 34 1 . 65 - - . 200
Mo. 147 295 - 6 350 67 9 27 96
N. Dak. 2 7 _ - 8 1 - 1 87
S. Dak. 11 2 . 1 37 10 - 5 144
Nebr. 15 15 . - 25 8 - 3 65
Kans. 40 54 - 3 77 10 2 20 82
S. ATLANTIC 8,632 8,721 . 82 4,662 12 54 473 2,077
Del. 43 25 - - 63 - - 4 5
Md 570 490 . 8 374 3 5 38 797
DC 374 472 U U 189 - 3 - 141
Va. 550 599 . 11 499 1 17 59 624
W. Va. 26 30 . . 132 . 2 12 114
N.C. 870 712 . 21 738 7 4 206 26
S.C 558 560 u U 440 - 2 80 36
Ga 1,523 1,804 - 11 815 1 2 68 209
Fla. 4,118 4.029 - 31 1,412 - 19 6 125
E.S. CENTRAL 2,088 2,242 . 27 2,043 23 10 108 356
Ky. 172 133 - - 507 1 3 24 83
Tenn. 574 644 - 13 628 17 2 49 188
Ala. 801 835 - 7 517 - 2 24 85
Miss. 541 630 - 7 391 5 3 11 -
W.S. CENTRAL 8,076 8,564 . 15 2,828 120 64 376 989
Ark. 187 217 . 2 348 70 4 42 158
La. 1,655 1,825 - 3 436 7 4 1 34
Okla. 194 185 - 10 276 32 2 233 104
Tex. 6,040 6,337 - - 1,768 11 54 100 693
MOUNTAIN 645 813 _ 11 614 42 23 14 233
Mont. 7 5 - . 42 6 1 6 68
Idaho 8 25 - . 29 2 1 3 16
Wyo. 12 16 u U 11 8 - 2 12
Colo. 155 230 - 5 89 14 1 - 32
N.Mex. 174 186 6 114 3 2 - 15
Ariz. 162 215 u U 253 1 16 1 36
Utah 23 24 - . 37 7 1 1 11
Nev. 104 112 - - 39 1 1 1 43
PACIFIC 5,159 4,511 _ 5 4,171 9 115 2 447
Wash. 186 169 _ . 230 2 5 - 2
Oreg. 146 113 . 2 179 3 4 - 1
Calif 4,735 4,106 u U 3.455 3 103 2 426
Alaska 14 15 . . 73 1 - - 18
Hawaii 78 108 - 3 234 - 3 - -
Guam . 1 u U 5 _ . . .
PR. 879 784 - . 455 . 1 - 49
VI. 19 31 - . 2 . 1 - -
Pac. Trust Terr. - - u U - - • *
U: Unavailable
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TABLE IV. Deaths in 121 U.S. cities,* *•week ending 
December 24, 1983 (51st week)
All Causibs. By Age (Years)
p&r*
Total
All Causes. By Age (Years)
Reporting Area All
Ages 2=65 45-64 25-44 1-24 <1
Reporting Area All
Ages 2=65 45-64 25-44 1-24 <1
P&l"
Total
S. ATLANTIC 1.201 739NEW ENGLAND 703 476
Boston, Mass 189 127
Bridgeport, Conn. 60 38
Cambridge, Mass. 21 16
Fall River, Mass. 24 18
Hartford, Conn. 68 44
Lowell, Mass 27 22
Lynn, Mass. 15 11
New Bedford, Mass. 25 18
New Haven, Conn. 67 41
Providence, R.l. 65 42
Somerville, Mass 15 12
Springfield, Mass. 46 26
Waterbury, Conn 34 29
Worcester, Mass 47 32
MID. ATLANTIC 2,679 1,772
Albany, N.Y. 41 33
Allentown, Pa. 18 14
Buffalo, N.Y. 142 99
Camden, N.J. 56 30
Elizabeth, N.J. 20 12
Erie, Pa t 39 28
Jersey City, N.J 43 30
N.Y. City, N.Y 1,467 957
Newark, N.J. 67 31
Paterson, N.J. 28 20
Philadelphia, Pa t 293 186
Pittsburgh, Pa t 70 43
Reading, Pa. 28 20
Rochester, N.Y. 131 90
Schenectady, N.Y. 29 19
Scranton, Pa t 34 24
Syracuse, N.Y. 80 60
Trenton, N.J. 34 25
Utica, N.Y 28 26
Yonkers, N.Y. 31 25
E.N. CENTRAL 2,238 1,655
Akron, Ohio 86 58
Canton, Ohio 43 29
Chicago, III § 526 478
Cincinnati, Ohio 157 109
Cleveland, Ohio 121 85
Columbus, Ohio 133 83
Dayton, Ohio 129 85
Detroit, Mich. 211 128
Evansville, Ind 38 24
Fort Wayne, Ind. 45 32
Gary, Ind. 11 6
Grand Rapids, Mich. 63 47
Indianapolis, Ind. 154 101
Madison, Wis 46 33
Milwaukee, Wis. 120 86
Peoria, III 79 54
Rockford, III. 36 24
South Bend, Ind 55 41
Toledo, Ohio § 119 112
Youngstown, Ohio 66 40
W.N. CENTRAL 740 465
Des Moines, Iowa 63 47
Duluth, Minn. 23 18
Kansas City, Kans. 38 25
Kansas City, Mo. 143 73
Lincoln, Nebr 36 25
Minneapolis, Minn. 66 32
Omaha, Nebr. 81 54
St. Louis, Mo. 148 97
St. Paul, Minn. 58 44
Wichita. Kans. 84 50
158 30 11 28 61
45 8 1 8 24
16 3 1 2 5
5 - - - -
6 - . . .
17 2 1 4 5
5 - - .
4 - . . .
5 1 1 - 1
10 5 2 9 5
14 4 2 3 6
3 - - . 1
15 3 1 1 4
4 1 - . 5
9 3 2 1 5
602 182 64 59 106
6 1 - 1 .
4 . . . .
30 4 6 3 9
15 3 4 4 1
6 1 1 . .
7 2 - 2 3
12 - - 1 1
316 130 38 26 52
17 12 2 5 4
7 - - 1 .
84 10 4 9 15
22 3 2 _ 5
6 - 2 . 3
30 4 3 4 9
6 4 - - .
10 - . . 1
14 2 2 2
4 5 . - .
2 - . . 1
4 1 - 1 2
381 82 52 55 88
17 7 3 1 _
11 2 - 1 3
5 6 15 11 11
33 7 4 4 18
25 8 2 1 2
35 6 4 5 5
37 3 1 3 3
61 13 5 4 3
11 2 1 . 3
9 2 1 1 2
4 1 - . 1
11 - 1 4 4
33 10 3 7 4
6 2 3 2 4
29 1 2 2 2
14 6 1 4 10
10 - 2 - 3
11 1 1 1 4
- 1 3 1 6
19 4 - 3 -
165 45 28 31 52
8 3 4 1 5
3 1 - 1 2
8 2 2 1 2
32 18 3 11 10
8 1 1 1 3
17 4 11 2 1
20 3 2 2 9
34 10 2 5 5
10 2 2 - .
25 1 1 7 15
Atlanta, Ga. 146 98
Baltimore, Md. 270 152
Charlotte, N.C. 77 50
Jacksonville, Fla. 116 83
Miami, Fla. 86 49
Norfolk, Va. 42 23
Richmond, Va. 77 38
Savannah, Ga. 48 34
St. Petersburg, Fla. 87 69
Tampa, Fla. 53 35
Washington, D C 160 87
Wilmington, Del. 39 21
E.S CENTRAL 668 501
Birmingham, Ala. 98 70
Chattanooga, Tenn. 54 42
Knoxville, Tenn 51 35
Louisville, Ky. 92 65
Memphis, Tenn. § 162 148
Mobile, Ala. 86 59
Montgomery, Ala. 29 23
Nashville. Tenn. 96 59
W S. CENTRAL 1,219 801
Austin, Tex. § 61 55
Baton Rouge, La 74 41
Corpus Christi, Tex 43 26
Dallas, Tex. 149 87
El Paso, Tex. 61 38
Fort Worth, Tex 76 54
Houston, Tex 263 125
Little Rock, Ark § 74 69
New Orleans, La § 23 107
San Antonio, Tex 170 97
Shreveport, La § 54 52
Tulsa, Okla 71 50
MOUNTAIN 609 394
Albuquerque, N.Mex 66 44
Colo Springs, Colo 46 33
Denver, Colo 110 71
Las Vegas, Nev 72 39
Ogden, Utah 26 17
Phoenix, Ariz 102 69
Pueblo, Colo 21 15
Salt Lake City, Utah 59 33
Tucson, Ariz 107 73
PACIFIC 1,749 1,144
Berkeley, Calif 11 7
Fresno, Calif 79 60
Glendale, Calif 17 13
Honolulu, Hawaii 59 36
Long Beach, Calif 112 78
Los Angeles, Calif 371 253
Oakland, Calif 112 78
Pasadena, Calif 38 30
Portland, Oreg. 112 69
Sacramento, Calif 69 45
San Diego, Calif 164 98
San Francisco, Calif 163 102
San Jose, Calif. 179 115
Seattle, Wash 146 82
Spokane, Wash 48 30
Tacoma, Wash. 69 48
TOTAL 11,806 7,947
284 100 38 40 60
25 10 3 10 6
70 32 12 4 5
18 4 3 2 7
20 8 3 2 13
26 7 2 2 2
9 4 . 6 3
27 6 3 3 8
9 3 2 . 3
13 4 . 1 5
13 3 . 2 4
43 14 8 8 3
11 5 2 - 1
102 29 15 18 36
15 10 1 2 1
6 1 - 5 5
12 2 1 1 3
19 3 4 1 8
- 3 5 3 12
19 3 . 5 4
5 1 . _ .
26 6 4 1 3
241 82 42 47 47
- 1 2 1 1
21 6 1 5 8
12 2 . 3 _
32 18 8 4 4
16 3 2 2 6
16 1 3 2 3
76 35 12 15 2
- 2 1 2 6
1 3 4 4 _








137 39 13 26 35
14 4 2 2 7
7 2 2 2 6
32 3 1 3 5
26 4 1 2 3
5 1 1 2 1
17 10 2 4 2
5 . . 1 1
13 6 2 5 2
18 9 2 5 8
353 108 55 84 105
4 . . . _
11 1 2 5 11
4 . . . 1
13 3 1 6 5
23 7 2 2 3
62 30 8 17 15
16 7 2 6 5
5 2 1 . 5
31 4 7 1 4
15 3 3 3 4
33 12 13 7 19
40 9 5 7 6
40 15 4 5 13
32 11 4 17 2
11 2 . 5 5
13 2 3 3 • 7
2,423 697 318 388 590
* Mortality data in this table are voluntarily reported from 121 cities in the United States, most of which have populations of 100 000 or 
more. A death is reported by the place of its occurrence and by the week that the death certificate was filed Fetal deaths are not 
included.
*• Pneumonia and influenza
t Because of changes in reporting methods in these 4 Pennsylvania cities, these numbers are partial counts for the current week Com­
plete counts will be available in 4 to 6 weeks
t t  Total includes unknown ages.
§ Data not available. Figures are estimates based on average of past 4 weeks.
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Since cat rabies cases now exceed those annually reported in dogs, immunization of 
cats must be emphasized. Such procedures in the United States have reduced 
laboratory-confirmed rabies cases in dogs from 8,000 in 1947 to 153 in 1982. The 
recommended vaccination procedures and the licensed animal vaccines are specified in 
Parts I and II of the NASPHV's annually released Compendium.
3. Rabies in W ild life: The control of rabies in foxes, skunks, raccoons, and other terrestri­
al animals is very difficult. Selective reduction of these populations, when indicated, 
may be useful, but the utility of this procedure depends heavily on the circumstances 
surrounding each rabies outbreak.
B. CONTROL M ETHO DS IN DOMESTIC AND CONFINED ANIMALS
1. Pre-exposure Vaccination and Management: Animal rabies vaccines, because of spe­
cies limitations, techniques, and tolerances, should be administered only by or under 
the direct supervision of a veterinarian. Within 1 month after vaccination, a peak rabies 
antibody titer is reached, and the animal can be considered immunized. (See Parts I and 
II of the Compendium for recommended vaccines and procedures.)
a. Dogs and Cats: All dogs and cats should be vaccinated against rabies commencing 
at 3 months of age and revaccinated in accordance with Part II of this Compendium.
b. Livestock: It is not economically feasible, nor is it justifiable from a public health 
standpoint, to vaccinate all livestock against rabies. Veterinary clinicians and owners 
of valuable animals may consider immunizing certain breeding stock located in areas 
where wildlife rabies is epizootic.
c. Other Animals:
(1 ) Animals Maintained in Exhibits and in Zoologic Parks: Captive animals not 
completely excluded from all contact with local vectors of rabies can become in­
fected with rabies. Moreover, such animals may be incubating rabies when 
captured. Exhibit animals, especially those carnivores and omnivores having con­
tact with the viewing public, should be quarantined for a minimum of 180 days. 
Since no rabies vaccine is licensed for use in wild animals, vaccination, even with 
inactivated vaccine, is not recommended. Pre-exposure rabies immunization of 
animal workers at such facilities is recommended to protect the workers and to 
reduce the need for euthanasia of valuable animals for rabies testing after they 
have bitten a handler.
(2) W ild  Animals: Because of the existing risk of rabies among wild animals, such as 
raccoons, skunks, and foxes, the American Veterinary Medical Association 
(AVMA), the NASPHV, and the Conference of State and Territorial Epidemiolo­
gists strongly recommend the enactment of state laws prohibiting the interstate 
and intrastate importation, distribution, and relocation of wild animals and wild 
animals cross-bred to domestic dogs and cats. Further, these same organizations 
continue to recommend the enactment of laws prohibiting the distribution and/or 
ownership of wild animals as pets.
2. Stray-Animal Control: Stray animals should be removed from the community, espe­
cially in rabies-epizootic areas. Local health department and animal-control officials can 
enforce the pick-up of strays more efficiently if owned animals are confined or leashed 
when not confined. Strays should be impounded for at least 3 days to give owners suf­
ficient time to reclaim animals apprehended as strays.
3. Quarantine:
a. International: Present USDA regulations (CFR No. 71154) governing the importa­
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tion of wild and domesticated felines, canines, and other potential rabies vectors are 
minimal for preventing the introduction of rabid animals into the United States. All 
dogs and cats imported from countries with endemic rabies should be vaccinated 
against rabies at least 30 days before entry into the United States.* The Centers for 
Disease Control (CDC) is responsible for these animals imported into the United 
States. CDC's requirements should be coordinated with interstate shipment 
requirements. The health authority of the state of destination should be notified 
within 72 hours of any animal conditionally admitted into its jurisdiction.
The conditional admission of such animals into the United States is subject to 
state and local laws governing rabies. Failures to comply with these requirements 
should be promptly reported to the director of CDC.
b. Interstate: Before interstate shipment, dogs and cats should be vaccinated against 
rabies according to the Compendium's recommendations and preferably shall be 
vaccinated at least 30 days before shipment. While in shipment, they should be ac­
companied by a currently valid NASPHV form #50, Rabies Vaccination Certificate. 
One copy of the certificate should be mailed to the appropriate Public Health Veter­
inarian or State Veterinarian of the state of destination.
c. Health Certificates: If a certificate is required for dogs and cats in transit, it must 
not replace the NASPHV rabies vaccination certificate.
4. Adjunct Procedures: Methods or procedures that enhance rabies control include:
a. Licensure: Registration or licensure of all dogs and cats may be used as a means of 
rabies control by controlling the stray-animal population. Frequently, a fee is 
charged for such licensure, and revenues collected are used to maintain a rabies- or 
animal-control program. Vaccination is usually recommended as a prerequisite to 
licensure.
b. Canvassing of Area: This includes house-to-house calls by members of the animal- 
control program to enforce vaccination and licensure requirements.
c. Citations: These are legal summonses issued to owners for violations, including fail­
ure to vaccinate or license their animals.
d. Leash Laws: All communities should adopt leash laws that can be incorporated in 
their animal-control ordinances.
5. Post-exposure Management:
ANY DOMESTIC ANIMAL THAT IS BITTEN OR SCRATCHED BY A BAT OR BY A WILD,
CARNIVOROUS MAMMAL THAT IS NOT AVAILABLE FOR TESTING SHOULD BE
REGARDED AS HAVING BEEN EXPOSED TO A RABID ANIMAL.
a. When bitten by a rabid animal, unvaccinated dogs and cats should be destroyed 
immediately. If the owner is unwilling to have this done, the unvaccinated animal 
should be placed in strict isolation for 6 months and vaccinated 1 month before 
being released. Dogs and cats that are currently vaccinated should be revaccinated 
immediately, leashed, and confined for 90  days.
b. All species of livestock are susceptible to rabies infection; cattle appear to be 
among the most susceptible of all domestic animal species. Livestock known to
*ln regard to cats, these recommendations do not conform to the official recommendations of CDC and 
the Public Health Service. Although domestic feline rabies has increased, there has been no evidence of 
increased risk of imported rabies in cats. U.S. Foreign Quarantine Regulations do not require rabies vacci­
nations for imported cats.
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have been bitten by rabid animals should be destroyed (slaughtered) immediately. If 
the owner is unwilling to have this done, the animal should be kept under very close 
observation for 6 months.
The following are recommendations to owners of livestock exposed to rabid 
animals:
(1) If slaughtered within 7 days of being bitten, tissues may be eaten without risk of 
infection, providing liberal portions of the exposed area are discarded. Federal 
meat inspectors will reject for slaughter any animal that has been exposed to 
rabies within 8 months.
(2) No tissues or secretions from a clinically rabid animal should be used for human 
or animal consumption. However, because pasteurization temperatures will inac­
tivate rabies virus, the drinking of pasteurized milk or eating of completely 
cooked meat does not constitute a rabies exposure.
C. CONTROL M ETHODS IN W ILD ANIMALS
1. Terrestrial Mammals: Since there is no evidence that these costly programs reduce 
either wildlife reservoirs or rabies incidence on a statewide basis, persistent, 
continuous, and routine trapping or poisoning campaigns as a means of wildlife rabies 
control should be abolished. However, limited control in high contact areas (picnic 
grounds, camps, suburban areas) may be indicated for the removal of selected, high- 
risk species of wild animals. The public should be warned not to handle wild animals. 
The state game department should be consulted early to manage any elimination pro­
grams when requested to do so by the state health department.
2. Bats:
a. Rabid bats have been reported from every state except Hawaii and have caused 
human rabies infections in the United States. It is neither feasible nor practical, 
however, to control rabies in bats by areawide bat-population reduction programs.
b. Bats should be eliminated from houses and surrounding structures to prevent direct 
association with people. Such structures should then be made bat-proof by sealing 
routes of entrance with screens or other means.
c. A person bitten by a bat or any wild animal should immediately report the incident to 
a physician who can evaluate the need for antirabies treatment (See current ACIP 
Rabies Prophylaxis Recommendation [MMW R  19 82 ;31 :279 -80 , 285]). Bats and 
wild carnivorous mammals, as well as wild animals cross-bred with domestic dogs 
and cats, that bite people should be killed, and appropriate tissues should be sent to 
the laboratory for examination for rabies.
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p. 536. In the article, "Enterovirus Surveillance — United States, 1983," the first full sen­
tence on p. 536 should read: "In 1982, it (Coxsackie B5) was the fifth most 
common isolate."
Vol. 32, No. 49
p. 637. In the article, "Diabetes and Pregnancy — Michigan, Missouri, South Carolina, 
Washington," the phrase, "odds ratio," should be "rate ratio" wherever it appears in 
the text and in Table 1.
Errata: Vol. 32, No. 41
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